Black sheep of the VEGF family gives hope for cancer therapy

Drug Discovery Today

Volumn 10, Issue 1, 2005, Pages 6-

  Ewan, Scott ^a  

^a NONE

Author keywords

Angiogenesis; Avastin; Biochemistry; Cancer biology; Drug Discovery; Hypertension; Monoclonal antibodies; Pharmaceutical Science; Splice variants

Indexed keywords

BEVACIZUMAB; CYTOTOXIC AGENT; NEW DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

BLOOD CLOTTING DISORDER; CANCER INHIBITION; CANCER THERAPY; CARDIOVASCULAR SYMPTOM; COLON DISEASE; COMPETITIVE INHIBITION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; DRUG TARGETING; HUMAN; HYPERTENSION; NOTE; PHARMACOLOGICAL BLOCKING; PROTEIN FAMILY;

EID: 12844272845     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03336-7     Document Type: Short Survey

References (1)

1. 165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64:2004;7822-7835